Novalija E, Fujita S, Kampine J P, Stowe D F
Department of Anesthesiology, The Medical College of Wisconsin, Veterans Affairs Medical Center, Milwaukee 53226, USA.
Anesthesiology. 1999 Sep;91(3):701-12. doi: 10.1097/00000542-199909000-00023.
Like ischemic preconditioning, certain volatile anesthetics have been shown to reduce the magnitude of ischemia/ reperfusion injury via activation of K+ adenosine triphosphate (ATP)-sensitive (K(ATP)) channels. The purpose of this study was (1) to determine if ischemic preconditioning (IPC) and sevoflurane preconditioning (SPC) increase nitric oxide release and improve coronary vascular function, as well as mechanical and electrical function, if given for only brief intervals before global ischemia of isolated hearts; and (2) to determine if K(ATP) channel antagonism by glibenclamide (GLB) blunts the cardioprotective effects of IPC and SPC.
Guinea pig hearts were isolated and perfused with Krebs-Ringer's solution at 55 mm Hg and randomly assigned to one of seven groups: (1) two 2-min total coronary occlusions (preconditioning, IPC) interspersed with 5 min of normal perfusion; (2) two 2-min occlusions interspersed with 5 min of perfusion while perfusing with GLB (IPC+GLB); (3) SPC (3.5%) for two 2-min periods; (4) SPC+GLB for two 2-min periods; (5) no treatment before ischemia (control [CON]); (6) CON+GLB; and (7) no ischemia (time control). Six minutes after ending IPC or SPC, hearts of ischemic groups were subjected to 30 min of global ischemia and 75 min of reperfusion. Left-ventricular pressure, coronary flow, and effluent NO concentration ([NO]) were measured. Flow and NO responses to bradykinin, and nitroprusside were tested 20-30 min before ischemia or drug treatment and 30-40 min after reperfusion.
After ischemia, compared with before (percentage change), left-ventricular pressure and coronary flow, respectively, recovered to a greater extent (P<0.05) after IPC (42%, 77%), and treatment with SPC (45%, 76%) than after CON (30%, 65%), IPC+GLB (24%, 64%), SPC+GLB (20%, 65%), and CON+GLB (28%, 64%). Bradykinin and nitroprusside increased [NO] by 30+/-5 (means +/- SEM) and 29+/-4 nM, respectively, averaged for all groups before ischemia. [NO] increased by 26+/-6 and 27+/-7 nM, respectively, in SPC and IPC groups after ischemia, compared with an average [NO] increase of 8+/-5 nM (P<0.01) after ischemia in CON and each of the three GLB groups. Flow increases to bradykinin and nitroprusside were also greater after SPC and IPC.
Preconditioning with sevoflurane, like IPC, improves not only postischemic contractility, but also basal flow, bradykinin and nitroprusside-induced increases in flow, and effluent [NO] in isolated hearts. The protective effects of both SPC and IPC are reversed by K(ATP) channel antagonism.
与缺血预处理相似,某些挥发性麻醉剂已被证明可通过激活钾离子三磷酸腺苷(ATP)敏感性(KATP)通道来减轻缺血/再灌注损伤的程度。本研究的目的是:(1)确定如果在离体心脏全心缺血前仅短暂给予缺血预处理(IPC)和七氟醚预处理(SPC),是否会增加一氧化氮释放并改善冠状动脉血管功能以及机械和电功能;(2)确定格列本脲(GLB)对KATP通道的拮抗作用是否会减弱IPC和SPC的心脏保护作用。
将豚鼠心脏离体,在55 mmHg下用 Krebs-Ringer 溶液灌注,并随机分为七组之一:(1)两次2分钟的完全冠状动脉闭塞(预处理,IPC),其间穿插5分钟的正常灌注;(2)两次2分钟的闭塞,其间穿插5分钟的灌注并同时灌注GLB(IPC+GLB);(3)两个2分钟的时间段给予SPC(3.5%);(4)两个2分钟的时间段给予SPC+GLB;(5)缺血前不进行处理(对照组[CON]);(6)CON+GLB;(7)不进行缺血处理(时间对照组)。在结束IPC或SPC后6分钟,对缺血组心脏进行30分钟的全心缺血和75分钟的再灌注。测量左心室压力、冠状动脉流量和流出液一氧化氮浓度([NO])。在缺血或药物处理前20-30分钟以及再灌注后30-40分钟测试对缓激肽和硝普钠的流量和NO反应。
缺血后,与缺血前相比(百分比变化),IPC(42%,77%)和SPC处理(45%,76%)后左心室压力和冠状动脉流量的恢复程度分别比CON(30%,65%)、IPC+GLB(24%,64%)、SPC+GLB(20%,65%)和CON+GLB(28%,64%)更大(P<0.05)。在缺血前,所有组缓激肽和硝普钠使[NO]分别平均增加30±5(均值±标准误)和29±4 nM。与CON组和三个GLB组缺血后平均[NO]增加8±5 nM相比(P<0.01),SPC组和IPC组缺血后[NO]分别增加26±6和27±7 nM。SPC和IPC后对缓激肽和硝普钠的流量增加也更大。
与IPC一样,七氟醚预处理不仅可改善缺血后收缩力,还可改善离体心脏的基础流量、缓激肽和硝普钠诱导的流量增加以及流出液[NO]。KATP通道拮抗作用可逆转SPC和IPC的保护作用。